Abstract:Objective: To evaluate the value of a machine learning model using enhanced CT radiomics features in the prediction of lymphovascular invasion (LVI) of esophageal squamous cell carcinoma (ESCC) before treatment. Methods: We reviewed and analyzed the enhanced CT images of 258 ESCC patients from June 2017 to December 2019. We randomly assigned the patients in a ratio of 7:3 to a training set (182 cases) and a validation (76 cases) set. Clinical risk factors and CT image characteristics were recorded, and multifactor logistic regression was used to screen independent risk factors of LVI of ESCC patients. We extracted the CT radiomics features using the FAE software and screened radiomics features using maximum relevance and minimum redundancy (MRMR) and least absolute shrinkage and selection operator (LASSO) algorithms, and finally, the radiomics labels of each patient were established. Five machine learning algorithms, namely, support vector machine (SVM), K-nearest neighbor (KNN), logistic regression (LR), Gauss naive Bayes (GNB), and multilayer perceptron (MLP), were used to construct the model of radiomics labels, and its clinical features were screened. The predictive efficacy of the machine learning model for LVI of ESCC was evaluated using the receiver operating characteristic (ROC) curve. Results: Tumor thickness [OR = 1.189, 95% confidence interval (CI) 1.060–1.351, P = 0.005], tumor-to-normal wall enhancement ratio (TNR) (OR = 2.966, 95% CI 1.174–7.894, P = 0.024), and clinical N stage (OR = 5.828, 95% CI 1.752–20.811, P = 0.005) were determined as independent risk factors of LVI. We extracted 1,316 features from preoperative enhanced CT images and selected 14 radiomics features using MRMR and LASSO to construct the radiomics labels. In the test set, SVM, KNN, LR, and GNB showed high predictive performance, while the MLP model had poor performance. In the training set, the area under the curve (AUC) values were 0.945 and 0.905 in the KNN and SVM models, but these decreased to 0.866 and 0.867 in the validation set, indicating significant overfitting. The GNB and LR models had AUC values of 0.905 and 0.911 in the training set and 0.900 and 0.893 in the validation set, with stable performance and good fitting and predictive ability. The MLP model had AUC values of 0.658 and 0.674 in the training and validation sets, indicating poor performance. A multiscale combined model constructed using multivariate logistic regression has an AUC of 0.911 (0.870–0.951) and 0.893 (0.840–0.962), accuracy of 84.4% and 79.7%, sensitivity of 90.8% and 87.1%, and specificity of 80.5% and 79.0% in the training and validation sets, respectively. Conclusion: Machine learning models can preoperatively predict the condition of LVI effectively in patients with ESCC based on enhanced CT radiomics features. The GNB and LR models exhibit good stability and may bring a new way for the non-invasive prediction of LVI condition in ESCC patients before treatment.

Predicting Lymph Node Metastasis Using Computed Tomography Radiomics Analysis in Patients with Resectable Esophageal Squamous Cell Carcinoma

Preoperative identification of small metastatic lymph nodes in esophageal squamous cell carcinoma using CT radiomics of lymph nodes

A 18F-FDG PET/CT-based Deep Learning-Radiomics-clinical Model for Prediction of Cervical Lymph Node Metastasis in Esophageal Squamous Cell Carcinoma

Radiomics-clinical nomogram for preoperative lymph node metastasis prediction in esophageal carcinoma

A Radiomics Nomogram for Non-Invasive Prediction of Progression-Free Survival in Esophageal Squamous Cell Carcinoma

CT Radiomics in the Identification of Preoperative Understaging in Patients with Clinical Stage T1-2N0 Esophageal Squamous Cell Carcinoma

Radiomics Analysis of Lymph Nodes with Esophageal Squamous Cell Carcinoma Based on Deep Learning

Computed Tomography-Based Radiomics Nomogram for Predicting the Postoperative Prognosis of Esophageal Squamous Cell Carcinoma: A Multicenter Study

Machine learning model based on enhanced CT radiomics for the preoperative prediction of lymphovascular invasion in esophageal squamous cell carcinoma

A machine learning radiomics based on enhanced computed tomography to predict neoadjuvant immunotherapy for resectable esophageal squamous cell carcinoma

[Application of a Radiomics Model for Preding Lymph Node Metastasis in Non-small Cell Lung Cancer]

Computed tomography-based radiomics nomogram for prediction of lympho-vascular and perineural invasion in esophageal squamous cell cancer patients: a retrospective cohort study

Evaluating peritumoral and intratumoral radiomics signatures for predicting lymph node metastasis in surgically resectable non-small cell lung cancer

Enhancing lymph node metastasis prediction in adenocarcinoma of the esophagogastric junction: A study combining radiomic with clinical features

Efficacy of radiomics model based on the concept of gross tumor volume and clinical target volume in predicting occult lymph node metastasis in non-small cell lung cancer

A radiomics nomogram for predicting postoperative recurrence in esophageal squamous cell carcinoma

Machine learning models predict lymph node metastasis in patients with stage T1-T2 esophageal squamous cell carcinoma

CT-based radiomics for predicting lymph node metastasis in esophageal cancer: a systematic review and meta-analysis

Predicting response to immunotherapy plus chemotherapy in patients with esophageal squamous cell carcinoma using non-invasive Radiomic biomarkers

A CT-based Radiomics Model for Prediction of Lymph Node Metastasis in Early Stage Gastric Cancer

Dual-region radiomics signature: Integrating primary tumor and lymph node computed tomography features improves survival prediction in esophageal squamous cell cancer